Cost-Effectiveness of Drug-Eluting Stents Versus Bare Metal Stents in Clinical Practice | Zendy

Pascha Schafer | Zendy; Matthew Sacrinty | Zendy; David J. Cohen | Zendy; Michael A. Kutcher | Zendy; Sanjay Gandhi | Zendy; Renato M. Santos | Zendy; William C. Little | Zendy; Robert J. Applegate | Zendy

AI Assistant Blog Pricing

Open Access

Cost-Effectiveness of Drug-Eluting Stents Versus Bare Metal Stents in Clinical Practice

Author(s) -

Pascha Schafer,

Matthew Sacrinty,

David J. Cohen,

Michael A. Kutcher,

Sanjay Gandhi,

Renato M. Santos,

William C. Little,

Robert J. Applegate

Publication year - 2011

Publication title -

circulation cardiovascular quality and outcomes

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.692

H-Index - 87

eISSN - 1941-7713

pISSN - 1941-7705

DOI - 10.1161/circoutcomes.110.960187

Subject(s) - medicine , clopidogrel , observational study , bare metal , cost effectiveness , drug eluting stent , emergency medicine , stent , aspirin , restenosis , risk analysis (engineering)

Drug-eluting stents (DES) reduce the need for repeat target revascularization (TVR) compared with bare metal stents (BMS) but are more costly. The objective was to evaluate the cost-effectiveness of DES versus BMS.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Our institutional solutions Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Discover

Explore

Home ZAIA Blog